Trademark: 87843838
Status Date
Tuesday, July 13, 2021
Registration Number
6420234
Registration Date
Tuesday, July 13, 2021
Filing Date
Wednesday, March 21, 2018
Published for Opposition
Tuesday, October 23, 2018
42 Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
44 Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
Jul 13, 2021
Registered-Principal Register
Jun 8, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 7, 2021
Allowed Principal Register - Sou Accepted
May 21, 2021
Statement Of Use Processing Complete
May 12, 2021
Use Amendment Filed
May 21, 2021
Case Assigned To Intent To Use Paralegal
May 12, 2021
Teas Statement Of Use Received
Feb 1, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2021
Teas Change Of Correspondence Received
Feb 1, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 1, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 1, 2021
Teas Change Of Owner Address Received
Feb 1, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 1, 2021
Teas Change Of Correspondence Received
Feb 1, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 1, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 1, 2021
Teas Change Of Owner Address Received
Dec 15, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2020
Extension 4 Granted
Dec 11, 2020
Extension 4 Filed
Dec 11, 2020
Teas Extension Received
Oct 12, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 12, 2020
Teas Change Of Correspondence Received
Oct 12, 2020
Teas Change Of Owner Address Received
Jul 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 8, 2020
Teas Change Of Correspondence Received
Jul 8, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 8, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 8, 2020
Teas Change Of Owner Address Received
Jun 20, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 18, 2020
Extension 3 Granted
Jun 18, 2020
Extension 3 Filed
Jun 18, 2020
Teas Extension Received
Dec 20, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2019
Extension 2 Granted
Dec 18, 2019
Extension 2 Filed
Dec 18, 2019
Teas Extension Received
Aug 14, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 14, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 18, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2019
Extension 1 Granted
Jun 14, 2019
Extension 1 Filed
Jun 14, 2019
Teas Extension Received
Dec 18, 2018
Noa E-Mailed - Sou Required From Applicant
Oct 23, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 23, 2018
Published For Opposition
Oct 3, 2018
Notification Of Notice Of Publication E-Mailed
Sep 20, 2018
Law Office Publication Review Completed
Sep 17, 2018
Assigned To Lie
Sep 5, 2018
Approved For Pub - Principal Register
Aug 6, 2018
Teas/Email Correspondence Entered
Aug 6, 2018
Correspondence Received In Law Office
Aug 6, 2018
Teas Response To Office Action Received
Jul 11, 2018
Notification Of Non-Final Action E-Mailed
Jul 11, 2018
Non-Final Action E-Mailed
Jul 11, 2018
Non-Final Action Written
Jul 2, 2018
Assigned To Examiner
Mar 28, 2018
New Application Office Supplied Data Entered In Tram
Mar 24, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
